Clinical trial with itraconazole in the treatment of Tinea cruris, Tinea corporis and tinea pedis interdigital

Authors

  • Clarisse Zaitz Santa Casa de São Paulo; Faculdade de Ciências Médicas
  • Ligia Rangel B. Ruiz Santa Casa de São Paulo; Setor de Dermatologia Infecciosa
  • Elizabeth Maria A. Drullis Santa Casa de São Paulo; Setor de Dermatologia Infecciosa
  • Perola Gurfinkel Santa Casa de São Paulo; Setor de Dermatologia Infecciosa
  • Mara Aparecida Ciarnuto Santa Casa de São Paulo; Setor de Dermatologia Infecciosa

Keywords:

Dermatofitoses, Itraconazol

Abstract

The authors studied 31 patients with Tinea cruris, corporis or pedis interdigital. The patients were treated with 100 mg of itraconazole, once a day, during the lunch, for 15 days. Mycological and clinical evaluations were performed at the pre-treatment, by the end of treatment and 2 weeks after finishing the treatment. The results showed that itraconazole is effective for the treatment of dermatophytosis, at the studied posology. with 100% of mycological cure. Clinical evaluation showed a significant reduction (Friedman test - p < 0.001) of signs and symptoms. No side-effect was registered.

Downloads

Download data is not yet available.

Published

1990-08-01

Issue

Section

Therapeutic Assays

How to Cite

Zaitz, C., Ruiz, L. R. B., Drullis, E. M. A., Gurfinkel, P., & Ciarnuto, M. A. (1990). Clinical trial with itraconazole in the treatment of Tinea cruris, Tinea corporis and tinea pedis interdigital . Revista Do Instituto De Medicina Tropical De São Paulo, 32(4), 299-303. https://revistas.usp.br/rimtsp/article/view/28749